Syra Health Corp. Class A Common Stock

Syra Health Corp. Class A Common Stock

SYRA
Syra Health Corp. Class A Common StockUS flagOther OTC
0.51
USD
+0.06
- -
5.78MMarket Cap
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
0.19
0.96
1.13
1.06
- -
0.64
Basic EPS, GAAP
- -
- -
-0.36
-0.6
-0.5
- -
-0.02
Free Cash Flow per Basic Share
- -
-0.01
-0.4
-0.57
-0.39
- -
0.06
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
- -
-0.36
-1.04
-1.17
- -
-0.79
Tangible Book Value per Share
- -
- -
0.12
0.82
0.38
- -
0.2
Basic Weighted Avg Shares
- -
7
6
5
8
- -
12
Sales/Revenue/Turnover
- -
1
6
6
8
7
8
Operating Margin (%)
- -
-0.23
-37.2
-52.36
-47.17
-12.51
-3.14
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
- -
-2
-3
-4
-1
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
-0.23
-37.71
-53.28
-47.1
-12.4
-2.4
Working Capital
- -
- -
- -
4
3
2
2
LT Debt
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
- -
1
4
3
2
2
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
1.78
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
12
12
12
Market Capitalization
1
1
3

Working Capital

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
3
3
4
Cash, Cash Equivalents & STI
2
2
3
Accounts Receivable, Net
1
1
1
Inventories
- -
- -
- -
Total Current Liabilities
1
1
2
Payables & Accruals
1
1
1
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
1

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-1,910.86%
-27.11%
Free Cash Flow
- -
- -
-84.78%
Net Income, GAAP
- -
- -
-76.16%
Sales/Revenue/Turnover
- -
- -
-9.47%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2
2
2
2
8
2025
2
2
2
2
7
2026
2
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.22
-0.21
-0.06
- -
-0.5
2025
-0.04
-0.01
-0.02
- -
- -
2026
0.02
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Gregory R. Alexander
Full Time Employees
57
Sector
Healthcare
Industry
Medical - Care Facilities
Address
1119 Keystone Way North Carmel DE United States of America 46032
IPO Date
Sep 29, 2023
Business
Syra Health Corp is a healthcare technology company specializing in digital health solutions with a primary focus on behavioral and mental health, population health management, health education, and healthcare workforce services. It offers core products including Syrenity, an AI-backed, evidence-based mental health app integrating telehealth for managing common mental health conditions, and CarePlus, a specialized Electronic Medical Record (EMR) system designed to optimize clinical workflows and enhance patient care. The company also provides population health contract services, healthcare workforce staffing solutions, and innovative training programs targeting payers, providers, life sciences organizations, academic institutions, and government agencies across the United States. Founded in 2015 and headquartered in Carmel, Indiana, Syra Health operates nationally with contracts in multiple states including Indiana, Tennessee, Arizona, and Virginia. Recent major developments include the 2024 launch of Syrenity, which drives the company's strategic shift toward scalable mental health technology solutions, backed by positive preliminary clinical study results. The company has secured several significant contracts extending its population health and healthcare workforce engagements, such as a $2.1 million contract to provide medical management nurses for a major insurance provider and multiple government agency contracts focused on healthcare quality improvement and population health initiatives. Syra Health also achieved ISO certification and reported a 45% year-on-year revenue increase in 2024 to $8 million, driven by growth in higher-margin population health services despite overall net losses attributed to upfront investments in product development and scaling of Syrenity. Additionally, Syra Health is actively pursuing acquisitions to expand its healthcare technology portfolio and maintain its growth trajectory. The company’s strategic focus encompasses accessible, affordable, and evidence-based healthcare solutions that reduce stigmas and increase care access, aiming to support both individual users and organizational clients. Syra Health’s offerings facilitate improved mental health outcomes, operational efficiency for healthcare providers, and equitable health services for payers and government bodies, reflecting its broad commitment to advancing healthcare through technology and expertise.

Company News

APIChat
  • Syra Health Delivers its First Profitable Quarter in Q1 2026, Expands Margins and Strengthens Financial Position

  • Syra Health To Announce First Quarter 2026 Financial Results

  • Syra Health Wins Innovation of the Year and BioCrossroads Life Sciences Innovation Award at the 2026 TechPoint Mira Awards

  • Syra Health (NASDAQ:SYRA) Trading 4.4% Higher – Should You Buy?

  • Syra Health and Nora Mental Health Announce Telehealth Partnership to Expand Access to Mental and Behavioral Health Services Across Indiana

  • Syra Health (NASDAQ:SYRA) Trading Up 4.5% – Here’s Why

  • Syra Health Posts Strong FY2025 Results with 157% Population Health Growth and 76% Net Loss Reduction: Targets Profitability by Year-End 2026

  • Syra Health To Announce Fourth Quarter and Full Year 2025 Financial Results

  • Syra Health Appoints Healthcare Executive and Former U.S. Marine Gregory R. Alexander as Chief Executive Officer to Drive Growth

  • Syra Health Announces Third Quarter Financial Results: Margins, Profitability Metrics Improve

  • Syra Health To Announce Third Quarter 2025 Financial Results

  • Syra Health Announces Second Quarter Financial Results, Advancing Toward Profitability on Margin Gains and Cost Reductions

  • Syra Health To Announce Second Quarter 2025 Financial Results

  • Syra Health Secures Contract Valued at Up to $2.1 Million to Provide Medical Management Nurses for Major Insurance Provider

  • Syra Health Earns ISO 27001:2022 Certification, Highlighting Company's Commitment to Data Protection

  • Syra Health Selected for $5.8 Million Indiana Child Mental Health Program

  • Syra Health Board Begins CEO Search to Drive Growth

  • Syra Health Corp. (SYRA) Q1 2025 Earnings Call Transcript

  • Syra Health Announces First Quarter Revenue of $1.9 Million, Up 6% YoY

  • Syra Health To Discuss First Quarter 2025 Financial Results